Table 3.
Model comparison assessing the specificity of treatment effect.
Data in the escitalopram group were fitted with the cost-evidence accumulation model. The parameters were fixed to the values fitted onto the placebo group, excepted when a modulation was permitted. The first row contains models that permit the modulation of one single parameter, whereas the remaining rows correspond to models that permit a combination of two modulations. Each cell gives log Bayes Factor (i.e. log model evidence) relative to the null model. Higher values denote better models.
Sem |
Sed |
Srm |
Sri |
Ai |
|
---|---|---|---|---|---|
Only one modulation |
173.6 |
19.9 |
−4.2 |
−3.8 |
3.7 |
Also includes Sem |
176.6 |
169.6 |
169.7 |
170.7 |
|
Also includes Sed |
15.7 |
16.1 |
21.7 |
||
Also includes Srm |
−7.3 |
−1.1 |
|||
Also includes Sri |
1.2 |